The invention provides compounds of formula (I), stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof: (I) wherein A1 to A6 and R1 to R4 are as defined herein. Such compounds are suitable for use in the treatment or prevention of diseases or conditions which are mediated by the activation of lactate dehydrogenase A (LDHA), for example cancer.
本发明提供了式(I)化合物、其立体异构体、同系物、药学上可接受的盐和原药:(I) 其中A1至A6和R1至R4如本文所定义。此类化合物适用于治疗或预防由
乳酸脱氢酶 A(L
DHA)活化介导的疾病或病症,例如癌症。